Teva, Bedford Labs antibiotic in short supply; FDA looks at ICH Q11 in draft guidance;

> Count antibiotic Amikacin injection among the drug shortages listed by the FDA. Both Teva and Bedford Labs cite manufacturing delays for lack of supply of 250 milligram per milliliter, 2- and 4-milliliter vials. Listing

> The FDA has published draft guidance for the ICH Q11 guideline on the development and manufacture of drug substances, which encompasses APIs and biopharmaceutical manufacturing. Article

> Combining its strengths in software and drug-making, India has convened a task force for developing anti-counterfeiting drug-tracking software. News

> Police raids of commercial buildings in the Thai city of Pattaya have uncovered more than $335,000 in illegal drugs, pirated clothing and smuggled cigarettes. Item

> Valeant Pharmaceuticals plans to move some U.S. production back to Canada within three years. Story

> Granules India of Hyderabad is setting up a bulk drugs and intermediaries manufacturing facility in Visakhapatnam with an investment of $20 million in joint venture with Belgium's Ajinomoto OmniChem. Report

> Ontario is helping Teva expand production, create jobs and save jobs at plants in Stouffville, Markham and Scarborough. Piece

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.